Petrovax begins dosing in Phase III trial of CanSino’s Covid-19 vaccine
Russia's Petrovax Pharm has started dosing participants in a Phase III clinical trial of Ad5-nCoV Covid-19 vaccine candidate developed by…
Latest News
-
4 hours
-
18 hours
-
23 hours
-
24 hours
-
4 days
-
4 days
-
4 days
-
5 days
BMS reports positive data of Opdivo in renal cell carcinoma trial
Bristol Myers Squibb (BMS) and Exelixis have reported that an Opdivo (nivolumab) and Cabometyx (cabozantinib) combination showed significant improvements across…
Latest News
View More
Roche’s Actemra reduces need for mechanised ventilation in Covid-19 patients
Roche has reported that its Actemra/RoActemra (tocilizumab) reduced the need for mechanical ventilation in hospitalised Covid-19 patients with associated pneumonia in the Phase III EMPACTA…
Atossa Therapeutics reports positive safety data of Covid-19 drug
Atossa Therapeutics has reported positive interim safety data from the second cohort of participants in a Phase I clinical trial of its Covid-19 drug candidate,…
Feinstein Institutes reports positive data of lupus nephritis drug
The Feinstein Institutes for Medical Research and Northwell Health’s Division of Rheumatology in the US have announced improved renal response…
Algernon to continue Phase IIb/III trial of Ifenprodil in Covid-19
The Data and Safety Monitoring Board (DSMB) has recommended Algernon Pharmaceuticals to continue its Phase IIb/III clinical trial of Ifenprodil…
Lilly reports Covid-19 antibody reduced rate of hospitalisation
Eli Lilly has reported positive proof-of-concept results from the BLAZE-1 clinical trial, which assessed SARS-CoV-2 neutralising antibody candidate LY-CoV555, to…
OPKO Health evaluates Rayaldee to treat Covid-19 patients
Biopharmaceutical company OPKO Health has launched a Phase II clinical trial to assess Rayaldee as a potential treatment for mild…
Company A-Z
View MoreFormedix
Cloud-Based Off-the-Shelf Clinical Metadata Repository and Clinical Trial Automation Software Platform
Jeeva Informatics Solutions
Artificial Intelligence (AI)-Driven Decentralised Clinical Trial Development
Latest Content
View More
Daiichi Sankyo to test patritumab deruxtecan for colorectal cancer
Daiichi Sankyo has started dosing patients in a Phase II clinical trial of patritumab deruxtecan (U3-1402) for the treatment of…
Pfizer says Covid-19 vaccine showed moderate side effects
Pfizer has said that Phase III clinical trial participants were experiencing mild-to-moderate side effects with its investigational Covid-19 vaccine candidate.…
Clinical Metadata Repository
The Formedix Clinical Metadata Repository (MDR) is a centralised, all-in-one, fully integrated clinical metadata repository. You can get started straight…
Annotated CRFs
Annotating CRFs (Case Report Forms) is an important but almighty task. You need to manually create annotations for every single…
Noble Life Sciences at World Vaccine Congress Washington 2020
Noble Life Sciences is pleased to announce that it will be exhibiting at World Vaccine Congress Washington 2020, a virtual…
MELACTOPLAN
A natural product without any side effects; for stress, anxiety, sleep or jet-lag. Melactoplan promotes relaxation and sleep due to…